Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • MEK
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

trametinib (dmso solvate)

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
Other Forms of Products
  • Trametinib-13C6
    TMID-0691
    Trametinib-13C6 is a 13C labeled version of Trametinib. Trametinib (T2125) (GSK1120212; JTP-74057) is an orally active MEK inhibitor with IC50 values of 2 nM for MEK1 and MEK2. It has the capability to activate autophagy and induce apoptosis.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Trametinib
    JTP-74057, GSK1120212
    T2125871700-17-3
    Trametinib (GSK1120212) is a MEK inhibitor that inhibits MEK1 and MEK2 (IC50=0.7/0.9 nM) with ATP non-competitive and oral activity. Trametinib activates autophagy and induces apoptosis.
    • $31
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • Trametinib-[13C6] (Standard)
    TMSM-5148
    Trametinib-[13C6] (Standard) is a reference standard of Trametinib-[13C6] intended for quantitative analysis, quality control, and related biochemical research applications.
    • $2,020
    4-6 weeks
    Size
    QTY
  • Trametinib-D4
    TMID-0655
    Trametinib-D4 is the deuterated form of Trametinib. Trametinib (T2125) (GSK1120212; JTP-74057) is an orally bioavailable MEK inhibitor, effectively inhibiting MEK1 and MEK2 with an IC50 of 2 nM. Additionally, Trametinib (T2125) can activate autophagy and induce apoptosis.
    • Inquiry Price
    Inquiry
    Size
    QTY